Human-centered Injury Thrivorship Pathway for Survivors of Physical Trauma

Survivorship Clinical Trial

Official title:

Identifying & Addressing Unmet Needs of Injury Survivors at a Safety Net Hospital in San Francisco

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06292039
• Other study ID #: P0555788
• Secondary ID: 2KL2TR001870
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 2025
• Est. completion date: June 2026

Study information

• Verified date: March 2024
• Source: University of California, San Francisco
• Contact: Marissa A Boeck, MD, MPH
• Phone: 415-502-4745
• Email: marissa.boeck[@]ucsf.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this clinical trial is to pilot and evaluate a human-centered injury thrivorship pathway in injury survivors. The main question it aims to answer is: • Is the pathway appropriate, acceptable, and feasible to meet the medical and social needs of injury survivors? Injury survivors will be purposively sampled to enroll in the pathway and asked to participate in in-depth interviews and their use of pathway resources will be tracked.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 25
• Est. completion date: June 2026
• Est. primary completion date: April 2026
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient = 18 years old presenting with a physical injury to Zuckerberg San Francisco General Hospital
• Admitted to the hospital = 24 hours
• Discharged from the hospital alive
• San Francisco resident or unhoused in San Francisco
• Capacity for informed consent

Exclusion Criteria:

• Patient < 18 years old
• Deceased during index hospitalization
• Unable to provide informed consent

Related Conditions & MeSH terms

• Injury Traumatic
• Survivorship
• Trauma Injury
• Wounds and Injuries

Intervention

Other:
• Human-Centered Injury Thrivorship Pathway
Enrollment in the human-centered injury thrivorship pathway.

Locations

Country	Name	City	State
United States	Zuckerberg San Francisco General Hospital	San Francisco	California

Sponsors (2)

Lead Sponsor	Collaborator
University of California, San Francisco	National Center for Advancing Translational Sciences (NCATS)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011 Mar;38(2):65-76. doi: 10.1007/s10488-010-0319-7. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Early Implementation Outcomes - Acceptability, Appropriateness, Feasibility	Early implementation outcomes will be assessed via purposive sampling of pathway participants, their caregivers, and trauma care stakeholders for in-depth semi-structured interviews. "Acceptability is the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Appropriateness is the perceived fit, relevance, or compatibility of the innovation or evidence based practice for a given practice setting, provider, or consumer; and/or perceived fit of the innovation to address a particular issue or problem. Feasibility is defined as the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting."	8-12 weeks post-pathway enrollment
Secondary	Participant pathway resource utilization - type	Participant engagement with applicable pathway resources will be tracked by type of resource(s) accessed	8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year
Secondary	Participant pathway resource utilization - frequency	Participant engagement with applicable pathway resources will be tracked by frequency of use of the resource(s)	8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year
Secondary	Participant pathway resource utilization - duration	Participant engagement with applicable pathway resources will be tracked by duration of use of the resource(s)	8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year
Secondary	Participant pathway resource utilization - % utilized	Participant engagement with applicable pathway resources will be tracked by overall % of resources utilized out of resource(s) offered	8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year